Figure 2:

Summary of HCC screening practice by survey respondents in special patient groups in which the evidence to base screening decisions is limited: HBV and concomitant NAFLD (regardless of age) (A), family history of HCC (regardless of age) (B), and non-Asian, non-African HBV patients (C)

HCC = hepatocellular carcinoma; HBV = hepatitis B virus; NAFLD = non-alcoholic fatty liver disease; F3 = advanced fibrosis; Q6M = every 6 months; Q12M = every 12 months